TERRAFORMATION
21.9.2022 15:09:38 CEST | Business Wire | Press release
Terraformation, the world’s first global forest carbon accelerator, today announces the launch of the Seed to Forest Alliance, with American Forests, Ecosystem Restoration Camps and One Tree Planted as founding members, as well as 1t.org US as an advisory partner.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220915005905/en/
Estimated Number of seed banks still needed per country based on low, medium and high “need for seeds scenarios". Source: Terraformation
Launching at Climate Week NYC 2022, the Alliance supports biodiverse, native reforestation by providing a network to connect forestry teams with financial and technical support; members, who will include corporates, NGOs, and philanthropists, will contribute to research and thought leadership to accelerate reforestation, and share results, best practices and expertise to help the reforestation movement overcome the largest bottlenecks to scale.
The Alliance will initially focus on inadequate seed supply as a barrier to reforestation at scale. New research published today by Terraformation sheds light on the significant scale of upgrades required in the world’s existing seed banking infrastructure to meet global restoration goals.
In recent years, global companies have committed to planting over 3.6 billion trees in their sustainability plans. At COP26, $7.2 billion of private investment was committed to protect and restore forests. However, these targets are not achievable without investment and innovation in global seed banking infrastructure.
Yishan Wong, founder and CEO of Terraformation, said: “Lasting climate solutions only come from collective action across diverse stakeholders. We’re incredibly excited to be working with organizations with the expertise, influence and determination to have a real impact on reforestation around the world. Native ecosystem restoration — with the right plants in the right places — is the most effective and immediately scalable carbon capture solution. Together, we can restore the future of our planet by conserving one of our most valuable resources at the heart of restoration: the seeds.”
Kevin O’Hara, Lead of 1t.org US at American Forests, added: “Time and time again we hear the real and immediate challenges in finding the seeds necessary to reach our ambitious national reforestation goals. 1t.org US is proud to support the work the Seed to Forest Alliance will do to help lift up public, private and NGO efforts to ramp up seed supply here in the US and around the world.”
New research reveals urgency for global seed bank network
Against this backdrop, Terraformation has published The Global Seed Bank Index, the first global review of seed banking infrastructure. The report analyzed the number of seed banks needed to meet the “global restoration potential,” defined as the area of land in the world available for ecological restoration.
The research found that a global decentralized seed bank network would drastically improve restoration outcomes, preserve threatened species, and benefit local communities.
Key findings include:
- Currently, 410 seed banks store native species for ecosystem restoration across 96 countries, but more are needed in almost all countries. Establishing larger regional seed banks could help meet the need for seeds more efficiently.
- More than half of the world’s countries have no known seed banks.
- While the United States, Australia, Brazil and China have the most seed banks, they also need the most new seed banks to meet their restoration potential within 10 years.
- The restoration movement will also need to train hundreds of thousands of new seed collectors to preserve and restore threatened biodiversity.
- The tropics and biodiversity hotspots are the highest priority locations for additional seed banking capacity given their high impact on biodiversity and climate regulation.
Following the study, Terraformation is calling on:
- Businesses to invest in seed banks in their sustainability plans: seed banks are a tangible restoration solution that directly support the UN’s Sustainable Development Goals.
- Governments to support seed banks as a natural resource management strategy: government support at any level can help create a well-connected and scalable decentralized network with locally adapted, resilient seeds.
- Local restoration organizations to prioritize seed banking: people already doing restoration on the ground can add seed banking to their restoration toolkits and scale their work with higher efficiency.
Seed to Forest Alliance
Terraformation and its Alliance members are committed to scaling solutions to the largest bottlenecks to native forest restoration. Four of the largest bottlenecks are inadequate seed supplies, a lack of on-the-ground technical expertise, data accessibility, and insufficient financing. The Alliance will first focus on seed supply, connecting forestry groups with the funding, technology and training to establish local seed supplies and enable biodiverse reforestation at scale.
The Alliance is underpinned by three guiding principles:
- Biodiversity and ecological resilience: the Alliance will only support native, biodiverse forest restoration in accordance with the IUCN Global Standard for Nature-based Solutions. It does not support monocultures or destructive forestry practices.
- Community: the Alliance believes communities are at the heart of resilient and just land restoration. It supports forest restoration projects in alignment with UN Sustainable Development Goals, especially with regard to gender equality, decent work, human health and well-being, and elimination of poverty.
- Measurable impact and transparency: the Alliance prioritizes impact, and as such will set quantifiable goals and transparently report progress.
The Global Seed Bank Index is available to download here.
- ENDS -
About Terraformation
Terraformation is dedicated to restoring the world's forests to stabilize our climate, revive ecosystems, and build thriving communities.
It is launching a forest carbon accelerator, supporting early-stage forestry teams to launch, build, and scale biodiverse reforestation projects and produce high-quality, verified carbon credits.
Terraformation’s partner network spans five continents and includes diverse landowners and organizations. It was founded in 2019 by Yishan Wong, former CEO of Reddit.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220915005905/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
